The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy

Name: The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy
License: Public Domain

The Affiliated Hospital of Qingdao University

ClinicalTrials.gov · Datasets · License: Public Domain

nsclc, angiogenesis, immunotherapy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 426763
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.